OR WAIT 15 SECS
© 2021 MJH Life Sciences™ and Applied Clinical Trials Online. All rights reserved.
Japanese CRO CMIC HOLDINGS has chosen goBalto’s Activate solution to further its clinical study startup process throughout Asia.
Japanese CRO CMIC HOLDINGS has chosen goBalto’s Activate solution to further its clinical study startup process throughout Asia. The CRO looks for the solution to improve workflows of studies being conducted in Malaysia, Singapore, Taiwan, Philippines, Thailand, Japan and South Korea.
Read the full release here
Related Content:
News